35 related articles for article (PubMed ID: 11745720)
1. Development of long-acting injectable suspensions by continuous antisolvent crystallization: An integrated bottom-up process.
Nandi S; Padrela L; Tajber L; Collas A
Int J Pharm; 2023 Dec; 648():123550. PubMed ID: 37890647
[TBL] [Abstract][Full Text] [Related]
2. Enhancing Flowability of Lamivudine through Quasi-Emulsion Solvent-Diffusion (QESD) Crystallization: A Comprehensive Study on Surfactant Impact, Particle Morphology by QbD concepts and Tablet Compression Challenges.
Sreeharsha N; Gajula LR; S SK; Bhavani PD; Goudanavar P; A R; Naveen NR; Shiroorkar PN; Meravanige G; Telsang M; Asif AH; Sreenivasalu PKP
Eur J Pharm Sci; 2024 Jun; ():106835. PubMed ID: 38908413
[TBL] [Abstract][Full Text] [Related]
3. Spherical Crystallization Based on Liquid-Liquid Phase Separation in a Reverse Antisolvent Crystallization Process.
Gong W; Li P; Rohani S
J Pharm Sci; 2024 Jun; 113(6):1616-1623. PubMed ID: 38311170
[TBL] [Abstract][Full Text] [Related]
4. Process intensification of atorvastatin calcium crystallization for target polymorph development via continuous combined cooling and antisolvent crystallization using an oscillatory baffled crystallizer.
Kshirsagar S; Lakshmi Ramana Susarla N; Ramakrishnan S; Nagy ZK
Int J Pharm; 2022 Nov; 627():122172. PubMed ID: 36084877
[TBL] [Abstract][Full Text] [Related]
5. Computer Aided Design of Solvent Blends for Hybrid Cooling and Antisolvent Crystallization of Active Pharmaceutical Ingredients.
Watson OL; Jonuzaj S; McGinty J; Sefcik J; Galindo A; Jackson G; Adjiman CS
Org Process Res Dev; 2021 May; 25(5):1123-1142. PubMed ID: 34295139
[TBL] [Abstract][Full Text] [Related]
6. Increasing the Batch Size of a QESD Crystallization by Using a MSMPR Crystallizer.
Hansen J; Kleinebudde P
Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745799
[TBL] [Abstract][Full Text] [Related]
7. Development, Optimization and Characterization of Eudraguard
Curcio C; Greco AS; Rizzo S; Saitta L; Musumeci T; Ruozi B; Pignatello R
Pharmaceuticals (Basel); 2020 Jun; 13(6):. PubMed ID: 32599861
[TBL] [Abstract][Full Text] [Related]
8. Role of solvents in improvement of dissolution rate of drugs: crystal habit and crystal agglomeration.
Maghsoodi M
Adv Pharm Bull; 2015 Mar; 5(1):13-8. PubMed ID: 25789214
[TBL] [Abstract][Full Text] [Related]
9. Development and optimization of polymeric self-emulsifying nanocapsules for localized drug delivery: design of experiment approach.
Wadhwa J; Asthana A; Gupta S; Shilkari Asthana G; Singh R
ScientificWorldJournal; 2014; 2014():516069. PubMed ID: 25525620
[TBL] [Abstract][Full Text] [Related]
10. How spherical crystallization improves direct tableting properties: a review.
Maghsoodi M
Adv Pharm Bull; 2012; 2(2):253-7. PubMed ID: 24312802
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of microparticles of piroxicam by spray drying and spray chilling methods.
Dixit M; Kini AG; Kulkarni PK
Res Pharm Sci; 2010 Jul; 5(2):89-97. PubMed ID: 21589797
[TBL] [Abstract][Full Text] [Related]
12. Definition of a solvent system for spherical crystallization of salbutamol sulfate by quasi-emulsion solvent diffusion (QESD) method.
Nocent M; Bertocchi L; Espitalier F; Baron M; Couarraze G
J Pharm Sci; 2001 Oct; 90(10):1620-7. PubMed ID: 11745720
[TBL] [Abstract][Full Text] [Related]
13. Particle design of tolbutamide by the spherical crystallization technique. III. Micromeritic properties and dissolution rate of tolbutamide spherical agglomerates prepared by the quasi-emulsion solvent diffusion method and the solvent change method.
Sano A; Kuriki T; Kawashima Y; Takeuchi H; Hino T; Niwa T
Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):733-9. PubMed ID: 2347016
[TBL] [Abstract][Full Text] [Related]
14. Towards a better understanding of the role of stabilizers in QESD crystallizations.
Hansen J; Kleinebudde P
Pharm Res; 2022 Dec; 39(12):3123-3136. PubMed ID: 35266086
[TBL] [Abstract][Full Text] [Related]
15. Improved aerosolization performance of salbutamol sulfate formulated with lactose crystallized from binary mixtures of ethanol-acetone.
Kaialy W; Ticehurst MD; Murphy J; Nokhodchi A
J Pharm Sci; 2011 Jul; 100(7):2665-84. PubMed ID: 21268026
[TBL] [Abstract][Full Text] [Related]
16. Spherical crystallization of drugs.
Kovačič B; Vrečer F; Planinšek O
Acta Pharm; 2012 Mar; 62(1):1-14. PubMed ID: 22472445
[TBL] [Abstract][Full Text] [Related]
17. Enhancing the solubility and bioavailability of poorly water-soluble drugs using supercritical antisolvent (SAS) process.
Abuzar SM; Hyun SM; Kim JH; Park HJ; Kim MS; Park JS; Hwang SJ
Int J Pharm; 2018 Mar; 538(1-2):1-13. PubMed ID: 29278733
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
